These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20512479)

  • 1. Genistein inhibits Vibrio vulnificus adhesion and cytotoxicity to HeLa cells.
    Oh DR; Kim JR; Kim YR
    Arch Pharm Res; 2010 May; 33(5):787-92. PubMed ID: 20512479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective mechanism of curcumin against Vibrio vulnificus infection.
    Na HS; Cha MH; Oh DR; Cho CW; Rhee JH; Kim YR
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):355-62. PubMed ID: 22092562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.
    Starks AM; Bourdage KL; Thiaville PC; Gulig PA
    Mol Microbiol; 2006 Jul; 61(2):310-23. PubMed ID: 16856938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
    Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
    J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of polygoni cuspidati radix and emodin on Vibrio vulnificus cytotoxicity and infection.
    Kim JR; Oh DR; Cha MH; Pyo BS; Rhee JH; Choy HE; Oh WK; Kim YR
    J Microbiol; 2008 Dec; 46(6):737-43. PubMed ID: 19107405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol modulates RTX toxin-induced cytotoxicity through interference in adhesion and toxin production.
    Kim JR; Cha MH; Oh DR; Oh WK; Rhee JH; Kim YR
    Eur J Pharmacol; 2010 Sep; 642(1-3):163-8. PubMed ID: 20553907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bactericidal activity of weakly acidic electrolyzed water (WAEW) against Vibrio vulnificus and Vibrio parahaemolyticus.
    Quan Y; Choi KD; Chung D; Shin IS
    Int J Food Microbiol; 2010 Jan; 136(3):255-60. PubMed ID: 20004034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pyrogallol on Growth and Cytotoxicity of Wild-Type and katG Mutant Strains of Vibrio vulnificus.
    Lim JY; Kim CM; Rhee JH; Kim YR
    PLoS One; 2016; 11(12):e0167699. PubMed ID: 27936080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefazolin plus minocycline against a clinical isolate of Vibrio vulnificus: in vitro and animal studies.
    Tang HJ; Ko WC; Chuang YC; Chen CC; Chiang SR
    Jpn J Infect Dis; 2010 Jan; 63(1):16-8. PubMed ID: 20093756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus.
    Lee B; Park J; Ryu M; Kim S; Joo M; Yeom JH; Kim S; Park Y; Lee K; Bae J
    Sci Rep; 2017 Oct; 7(1):13572. PubMed ID: 29051620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIDS inhibits Vibrio vulnificus cytotoxicity by interfering with TolC-mediated RtxA1 toxin secretion.
    Guo RH; Gong Y; Kim SY; Rhee JH; Kim YR
    Eur J Pharmacol; 2020 Oct; 884():173407. PubMed ID: 32735984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and antibiotics in Vibrio vulnificus septicemia.
    Liu JW; Lee IK; Tang HJ; Ko WC; Lee HC; Liu YC; Hsueh PR; Chuang YC
    Arch Intern Med; 2006 Oct; 166(19):2117-23. PubMed ID: 17060542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anti-Vibrio vulnificus activity of psammaplin A, a natural marine compound.
    Lee BC; Lee A; Jung JH; Choi SH; Kim TS
    Mol Med Rep; 2016 Sep; 14(3):2691-6. PubMed ID: 27431807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus.
    Wong TW; Wang YY; Sheu HM; Chuang YC
    Antimicrob Agents Chemother; 2005 Mar; 49(3):895-902. PubMed ID: 15728881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperbaric oxygen on Vibrio vulnificus and murine infection caused by it.
    Tamura T; Iida K; Saito M; Shiota S; Nakayama H; Yoshida S
    Microbiol Immunol; 2012 Oct; 56(10):673-9. PubMed ID: 22775062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Vibrio vulnificus type IV pilin contributes to biofilm formation, adherence to epithelial cells, and virulence.
    Paranjpye RN; Strom MS
    Infect Immun; 2005 Mar; 73(3):1411-22. PubMed ID: 15731039
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kim SE; Kim HK; Choi SM; Yu Y; Kim UJ; Darboe KS; Kang SJ; Park KH; Kang G; Kim YR; Rhee JH; Jung SI; Jang HC
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antimicrobial activity of water-soluble chitosan oligosaccharides against Vibrio vulnificus.
    Lee BC; Kim MS; Choi SH; Kim KY; Kim TS
    Int J Mol Med; 2009 Sep; 24(3):327-33. PubMed ID: 19639224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibrio vulnificus damages macrophages during the early phase of infection.
    Tsuchiya T; Mitsuo E; Hayashi N; Hikita Y; Nakao H; Yamamoto S; Miyamoto K; Tsujibo H
    Infect Immun; 2007 Sep; 75(9):4592-6. PubMed ID: 17591793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
    Jang HC; Choi SM; Kim HK; Kim SE; Kang SJ; Park KH; Ryu PY; Lee TH; Kim YR; Rhee JH; Jung SI; Choy HE
    PLoS One; 2014; 9(6):e101118. PubMed ID: 24978586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.